PARD6A Antibodies

Santa Cruz Biotechnology offers a broad range of PARD6A monoclonal antibodies for research focused on understanding PARD6A protein functions. PARD6A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PARD6A, or Partitioning Defective 6 Homolog Alpha, functions as a critical component of the cell polarity machinery, playing a significant role in the establishment and maintenance of cell polarity. PARD6A contributes to various cellular processes, including epithelial cell differentiation and tissue organization. Research involving PARD6A has revealed its importance in developmental biology and cancer progression. Scientists can utilize PARD6A monoclonal antibodies to explore cellular mechanisms and signaling pathways associated with PARD6A activity. Advanced research techniques incorporating PARD6A monoclonal antibodies enable detailed investigation of protein interactions and cellular localization patterns. Investigating PARD6A expression and regulation provides valuable insights into fundamental biological processes. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular organization and disease mechanisms.